IGM-7354

· IGM Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IGM-7354, covering 2024-07-24 to 2024-07-24. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of IGM-7354 in Adults With Relapsed and/or Refractory Cancer [Phase 1]